Advertisement
Screener

Connect Biopharma Holdings Limited (CNTB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Connect Biopharma Holdings Limited Cash Flow Breakdown

Cash flow breakdown shows where Connect Biopharma Holdings Limited's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $51.21M went out.
  • Fiscal year ended 2025-12-31: from investing, $9.82M came in.
  • Fiscal year ended 2025-12-31: from financing, $1.09M came in.
  • Fiscal year ended 2025-12-31: change in cash, $39.89M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldChange in cash
2025-12-31-$51.21M$9.82M$875.00K-$39.89M
2024-12-31-$23.61M-$3.45M$194.00K-$27.43M
2023-12-31-$47.74M$74.98M$1.00K$26.72M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$15.92M*-$4.47M*$0.00*$1.33M*
2026-03-31-$16.00M$6.00M$137.00K$17.48M*$7.69M
2025-12-31-$11.25M*$10.98M*$640.00K*
2025-09-30-$17.41M*$14.35M*$215.00K*
2025-06-30-$12.59M*$5.13M*$18.00K*
2025-03-31-$9.96M-$20.64M$2.00K-$30.52M
2024-12-31-$2.32M*-$15.76M*$93.00K*
2024-09-30-$13.01M*-$147.00K*$0.00*
2024-06-30-$7.70M*$3.21M*$101.00K*
2024-03-31-$591.00K$9.25M$0.00$8.44M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Yarrow Bioscience, Inc. (YARW)United States$0.070B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
XBiotech Inc. (XBIT)United States$0.066B-1.56
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
HYPERION DEFI, INC. (HYPD)United States$0.065B
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57